Doherty Catherine T.
SEC CIK 1520897 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics | SVP, Regional Businesses | 67.1K | — | $29.12M | 45 | 2021-11-29 | 2026-03-05 |
Most active insiders at DGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis J. E. | CEO, Pres, Dir | — | $17.08M |
| 2 | Doherty Catherine T. | EVP, Regional Businesses | — | $6.96M |
| 3 | PREVOZNIK MICHAEL E | SVP, GC | — | $6.69M |
| 4 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | — | $2.17M |
| 5 | Plewman Patrick | SVP for Diagnostic Services | — | $2.03M |
| 6 | DELANEY MARK E | SVP, Chief Commercial Off | — | $1.86M |
| 7 | PFEIFFER GARY M | Dir | — | $270.3K |
| 8 | Gregg Vicky B | Dir | — | $239.7K |
| 9 | Lassiter Wright III | Dir | — | — |
| 10 | Deppe Michael J | SVP, CAO, Corp. Ctrl | — | — |
Transactions 45
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | 2026-03-05 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $206.21 | -5,558 | 67.1K | -8% | -$1.15M | |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $204.86 | -5,806 | 72.7K | -7% | -$1.19M | |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | A - Grant | $204.86 | +11.4K | 78.5K | +17% | +$2.33M | |
| 2026-03-04 | 2026-03-03 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $207.73 | -632 | 67.1K | -0.9% | -$131.3K | |
| 2026-03-04 | 2026-03-02 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $204.86 | -648 | 67.8K | -0.9% | -$132.7K | |
| D | 2026-02-20 | 2026-02-19 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $204.83 | -1,433 | 68.4K | -2% | -$293.5K |
| D | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | A - Grant | $0.00 | +2,928 | 71.0K | +4% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $208.12 | -1,161 | 69.8K | -2% | -$241.6K |
| D | 2026-02-17 | 2026-02-13 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | M - OptEx | $112.17 | +26.2K | 94.2K | +38% | +$2.93M |
| DM | 2026-02-17 | 2026-02-13 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale+OE | $206.15 | -26.2K | 70.0K | -27% | -$5.39M |
| 2025-03-07 | 2025-03-05 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $174.13 | -5,370 | 68.1K | -7% | -$935.1K | |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | A - Grant | $173.74 | +10.4K | 78.4K | +15% | +$1.80M | |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $175.79 | -716 | 68.1K | -1% | -$125.9K | |
| M | 2025-03-05 | 2025-03-03+ | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $173.74 | -5,404 | 68.8K | -7% | -$938.9K |
| 2025-02-28 | 2025-02-27 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $172.61 | -824 | 69.2K | -1% | -$142.2K | |
| 2025-02-28 | 2025-02-26 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $171.75 | -455 | 70.0K | -0.6% | -$78.1K | |
| M | 2025-02-21 | 2025-02-19+ | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $170.51 | -1,434 | 71.4K | -2% | -$244.5K |
| D | 2025-02-14 | 2025-02-12 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | A - Grant | $0.00 | +3,479 | 71.9K | +5% | $0 |
| DM | 2024-12-02 | 2024-11-27 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale+OE | $162.99 | -33.1K | 96.7K | -26% | -$5.40M |
| D | 2024-12-02 | 2024-11-27 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | M - OptEx | $103.57 | +33.1K | 101.5K | +48% | +$3.43M |
| M | 2024-03-01 | 2024-02-28+ | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $126.45 | -6,744 | 68.4K | -9% | -$852.8K |
| M | 2024-03-01 | 2024-02-28 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $126.36 | -1,201 | 75.7K | -2% | -$151.8K |
| 2024-02-27 | 2024-02-23 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $125.02 | -3,757 | 76.4K | -5% | -$469.7K | |
| 2024-02-27 | 2024-02-23 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | A - Grant | $125.02 | +9,314 | 80.1K | +13% | +$1.16M | |
| 2024-02-23 | 2024-02-22 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $126.14 | -821 | 70.8K | -1% | -$103.6K | |
| 2024-02-23 | 2024-02-21 | DGX | Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $125.02 | -493 | 71.6K | -0.7% | -$61.6K | |
| D | 2024-02-16 | 2024-02-14 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | A - Grant | $0.00 | +4,304 | 72.1K | +6% | $0 |
| 2023-03-08 | 2023-03-06 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | A - Grant | $147.86 | +9,917 | 77.7K | +15% | +$1.47M | |
| 2023-03-08 | 2023-03-07 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | S - Sale | $140.55 | -5,307 | 67.8K | -7% | -$745.9K | |
| 2023-03-08 | 2023-03-06 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | F - Tax | $147.86 | -4,610 | 73.1K | -6% | -$681.6K | |
| 2023-03-06 | 2023-03-03 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | S - Sale | $140.63 | -717 | 67.8K | -1% | -$100.8K | |
| 2023-03-03 | 2023-03-01 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | F - Tax | $140.69 | -392 | 68.5K | -0.6% | -$55.2K | |
| D | 2023-02-27 | 2023-02-23 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | F - Tax | $147.86 | -962 | 66.8K | -1% | -$142.2K |
| D | 2023-02-27 | 2023-02-23 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | A - Grant | $0.00 | +3,838 | 70.6K | +6% | $0 |
| D | 2023-02-27 | 2023-02-24 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | S - Sale | $141.42 | -1,690 | 68.9K | -2% | -$239.0K |
| D | 2022-11-29 | 2022-11-28 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | M - OptEx | $86.63 | +40.8K | 108.5K | +60% | +$3.53M |
| DM | 2022-11-29 | 2022-11-28 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Regional Businesses | S - Sale+OE | $149.18 | -40.8K | 91.1K | -31% | -$6.08M |
| 2022-03-09 | 2022-03-08 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | S - Sale | $135.21 | -7,032 | 67.7K | -9% | -$950.8K | |
| 2022-03-09 | 2022-03-07 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | A - Grant | $130.09 | +13.4K | 81.1K | +20% | +$1.74M | |
| 2022-03-09 | 2022-03-07 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | F - Tax | $130.09 | -6,360 | 74.8K | -8% | -$827.4K | |
| D | 2022-02-28 | 2022-02-24 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | A - Grant | $0.00 | +3,328 | 67.7K | +5% | $0 |
| D | 2022-02-28 | 2022-02-24 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | S - Sale | $126.26 | -2,750 | 64.4K | -4% | -$347.2K |
| M | 2022-02-25 | 2022-02-23 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | F - Tax | $130.13 | -1,574 | 67.6K | -2% | -$204.8K |
| D | 2021-12-01 | 2021-11-29 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | M - OptEx | $95.80 | +37.6K | 106.3K | +55% | +$3.60M |
| DM | 2021-12-01 | 2021-11-29 | DGX | Quest Diagnostics | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | S - Sale+OE | $156.81 | -37.6K | 83.3K | -31% | -$5.89M |
Purchase Sale Sale after option exercise All abbreviations